Peter Jenkins is a Guarantors of Brain funded Clinical Fellow. He has a BMBCh from Oxford University and a Double First in Natural Sciences from Cambridge University.
The aims of his research are to investigate the role of dopamine dysregulation in traumatic brain injury and how this affects cognition.
et al., 2018, Dopaminergic abnormalities following traumatic brain injury, Brain, Vol:141, ISSN:0006-8950, Pages:797-810
et al., 2018, Minocycline reduces chronic microglial activation after brain trauma but increases neurodegeneration, Brain, Vol:141, ISSN:0006-8950, Pages:459-471
et al., 2018, Altered caudate connectivity is associated with executive dysfunction after traumatic brain injury, Brain, Vol:141, ISSN:0006-8950, Pages:148-164
et al., 2017, Serum Insulin-like Growth Factor-I Levels are Associated with Improved White Matter Recovery after Traumatic Brain Injury, Annals of Neurology, Vol:82, ISSN:0364-5134, Pages:30-43
Jenkins PO, Mehta MA, Sharp DJ, 2016, Catecholamines and cognition after traumatic brain injury, Brain, Vol:139, ISSN:0006-8950, Pages:2345-2371